Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
MyMD Pharmaceuticals, Inc. | Director | Employee Stock Option (Right to Buy) | 150K | Jun 7, 2023 | Direct | ||
Sidus Space Inc. | Chief Financial Officer | Stock Options | 25K | Feb 20, 2024 | Direct | ||
Intellicheck, Inc. | CFO, COO, Secretary & Treas | Restricted Stock Unit | 24.2K | Mar 31, 2022 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
SIDU | Sidus Space Inc. | Feb 20, 2024 | 1 | $0 | 4 | Feb 21, 2024 | Chief Financial Officer |
SIDU | Sidus Space Inc. | Feb 20, 2024 | 0 | $0 | 3 | Feb 20, 2024 | CFO |
MYMD | MyMD Pharmaceuticals, Inc. | Jun 7, 2023 | 1 | $0 | 4 | Jun 9, 2023 | Director |
COMS | COMSovereign Holding Corp. | Apr 26, 2023 | 0 | $0 | 3 | May 1, 2023 | Director |
PRPH | ProPhase Labs, Inc. | May 23, 2022 | 0 | $0 | 3 | May 23, 2022 | Chief Financial Officer |
IDN | Intellicheck, Inc. | Dec 7, 2021 | 1 | $5.25K | 4 | Dec 8, 2021 | CFO, COO, Secretary & Treas |
MYMD | MyMD Pharmaceuticals, Inc. | Oct 14, 2021 | 1 | $0 | 4 | Oct 15, 2021 | Director |
IDN | Intellicheck, Inc. | Jun 30, 2021 | 5 | $0 | 4 | Apr 15, 2022 | CFO, COO, Secretary & Treas |